MedTrace Logo

Serum Interleukin - 17A in Juvenile Idiopathic Arthritis

NCT05688358 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 78

Last updated 2023-01-18

No results posted yet for this study

Summary

1. This study aims to determine the serum levels of interleukin-17A (IL-17A) in children with juvenile idiopathic arthritis (JIA)
2. Analyze the correlation between IL-17A values and disease activity, certain clinical features, and laboratory markers of inflammation.

Conditions

  • JIA

Interventions

DIAGNOSTIC_TEST

serum levels of interleukin-17A in JIA

IL17 A by Enzyme linked immunosorbent assay method

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2025-05-01
Completion
2025-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05688358 on ClinicalTrials.gov